咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Adiponectin:mechanisms and new... 收藏

Adiponectin:mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning

Adiponectin : 为恢复糖尿病的心敏感到 ischemic 的机制和新治疗学的途径调节以后

作     者:Tingting Wang Shanglong Yao Zhengyuan Xia Michael G.Irwin 

作者机构:Department of Anesthesiology and Critical CareUnion HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430022China Department of AnesthesiologyThe University of Hong KongHong Kong SARChina 

出 版 物:《Frontiers of Medicine》 (医学前沿(英文版))

年 卷 期:2013年第7卷第3期

页      面:301-305页

核心收录:

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主  题:adiponectin ischemic post-conditioning ischemia reperfusion injury diabetes 

摘      要:Systemic inflammatory response following myocardial ischemia-reperfusion injury(IRI)to a specific organ may cause *** post-conditioning(IPostC)has emerged as a promising method for myocardial protection against IRI both in experimental and in clinical *** of endogenous nitric oxide(NO)is one of the major mechanisms by which IPostC confers ***,the sensitivity of the diabetic heart to IPostC is impaired and the underlying mechanism is ***(APN)is an adipocyte-derived plasma protein with anti-diabetic and anti-inflammatory *** levels of APN are decreased in obese subjects and in patients with type 2 *** supplementation has been shown to increase NO production and attenuate myocardial IRI in normal(non-diabetic)***,the effect of APN on myocardial injury in diabetic subjects,especially its potential in restoring the sensitivity of the diabetic heart to IPostC has not been *** the current paper,we discussed the possible reasons why the myocardium of diabetic subjects loses sensitivity to IPostC and also highlighted the potential effectiveness and mechanism of APN in restoring IPostC cardioprotection in *** review proposes to conduct studies that may facilitate the development of novel and optimal therapies to enhance cardioprotection in patients with severe diseases such as diabetes.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分